Treatment outcomes and relative dose intensity of chemotherapy in patients with advanced Hodgkin lymphoma

Author:

Rožman Samo1,Novaković Barbara2,Gorenjec Nina3,Novaković Srdjan4

Affiliation:

1. Pharmacy Department, Institute of Oncology Ljubljana, 1000 Ljubljana, Slovenia

2. The Department of Lymphoma Treatment, Division of Medical Oncology, Institute of Oncology Ljubljana, 1000 Ljubljana, Slovenia

3. Institute for Biostatistics and Medical Informatics, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia

4. Department of Molecular Diagnostics, Institute of Oncology Ljubljana, 1000 Ljubljana, Slovenia

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference29 articles.

1. Hodgkin lymphoma: A review and update on recent progress;Shanbhag;CA Cancer J Clin,2018

2. SEER cancer statistics review, 1975–2017, https://seer.cancer.gov/csr/1975_2017/, based on November 2019 SEER data submission, posted to the SEER web site;Howlader,2020

3. Racial disparities in Hodgkin's lymphoma: A comprehensive population-based analysis;Evens;Ann Oncol,2012

4. Cancer burden in Slovenia with the time trends analysis;Zadnik;Radiol Oncol,2017

5. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: The Lugano classification;Cheson;J Clin Oncol,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3